Search

everythinglearnresearchcommunity

for

Search:↓

Humans lost body hair relatively recently in evolution.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Skin aging is due to impaired stem cell mobilization or fewer responsive stem cells.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Hair follicles may soon be used more for targeted and systemic drug delivery.

Nanoparticles can improve skin drug delivery but have challenges like toxicity and stability that need more research.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

PEVs improve minoxidil skin penetration, increasing hair growth.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Liposomes and niosomes improve finasteride delivery for hair loss treatment.

Testosterone's muscle-building effects do not require its conversion to DHT.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Higher doses of cranial irradiation are linked to permanent hair loss.

Nanozymes show promise for effective and safe cancer treatment.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

The TGM3 gene's promoter region is key for skin and hair cell function and may aid gene therapy.

Cystatin M/E strongly inhibits cathepsin V and cathepsin L, important for skin formation.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Minoxidil helped bald patient regrow hair.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Pregnancy increases certain GABA_A receptors in rat brains, influenced by steroid levels.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

mTOR signaling helps activate hair stem cells by balancing out the suppression caused by BMP during hair growth.